ABBV Abbvie Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ABBV

Price (delayed)

$257.12

Market cap

$454.36B

P/E Ratio

72.43

Dividend/share

$6.83

EPS

$3.55

Enterprise value

$518.61B

?
Relative Growth: Rel. Growth: 78
Relative Strength: Rel. Strength: 68
Relative Valuation: Rel. Valuation: 25
Relative Profitability: Rel. Profitability: 67

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable ...

Highlights
The EPS has soared by 75% from the previous quarter and by 68% YoY
The company's net income has surged by 74% QoQ and by 68% YoY
ABBV's P/E is 35% below its last 4 quarters average of 112.1 but 23% above its 5-year quarterly average of 58.8
The quick ratio has contracted by 6% from the previous quarter but it has grown by 2.1% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.abbvie.com
Peers: PFE BMY LLY AMGN

Key stats

What are the main financial stats of ABBV

ABBV stock price

How has the Abbvie stock price performed over time
Intraday
0.83%
1 week
0.26%
1 month
2.81%
1 year
16.76%
YTD
12.53%
QTD
2.18%

Financial performance

How have Abbvie's revenue and profit performed over time
Revenue
$64.39B
Gross profit
$46.02B
Operating income
$16.87B
Net income
$6.31B
Gross margin
71.5%
Net margin
9.8%
The company's net income has surged by 74% QoQ and by 68% YoY
The net margin has surged by 69% since the previous quarter and by 51% year-on-year
The operating income has soared by 54% YoY and by 10% from the previous quarter
The operating margin rose by 39% year-on-year and by 7% since the previous quarter

Price vs fundamentals

How does ABBV's price correlate with its fundamentals

Growth

What is Abbvie's growth rate over time

Valuation

What is Abbvie stock price valuation
ABBV P/E details
P/E
72.43
P/B
N/A
P/S
7.06
EV/EBIT
45.74
EV/EBITDA
27
EV/Sales
8.05
The EPS has soared by 75% from the previous quarter and by 68% YoY
ABBV's P/E is 35% below its last 4 quarters average of 112.1 but 23% above its 5-year quarterly average of 58.8
Abbvie's equity has increased by 11% from the previous quarter
ABBV's P/S is 31% above its 5-year quarterly average of 5.4 and 7% above its last 4 quarters average of 6.6
ABBV's revenue is up by 10% year-on-year and by 2.5% since the previous quarter

Efficiency

How efficient is Abbvie business performance
Abbvie's ROIC has soared by 95% YoY and by 30% from the previous quarter
The ROS has soared by 85% YoY and by 28% from the previous quarter
Abbvie's return on assets has surged by 74% QoQ and by 74% YoY

Dividends

What is ABBV's dividend history
Dividend details
DPS
$6.83
Dividend yield
2.66%
Payout ratio
192.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbvie financials performed over time
Abbvie's total assets is 4.2% lower than its total liabilities
ABBV's current ratio is up by 9% year-on-year
The quick ratio has contracted by 6% from the previous quarter but it has grown by 2.1% YoY
The company's debt to equity has surged by 97% YoY but it fell by 9% QoQ
Abbvie's equity has increased by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.